EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

Journal of Clinical Oncology

Volumn 16, Issue 4, 1998, Pages 1248-1255

  De Alava, Enrique ^b   Kawai, Akira ^b   Healey, John H ^b   Fligman, Igal ^b   Meyers, Paul A ^b   Huvos, Andrew G ^b   Gerald, William L ^b   Jhanwar, Suresh C ^b   Argani, Pedram ^b   Antonescu, Cristina R ^b   Pardo Mindan, F Javier ^b   Ginsberg, Jill ^b   Womer, Richard ^b   Lawlor, Elizabeth R ^b   Wunder, Jay ^b   Andrulis, Irene ^b   Sorensen, Poul H B ^b   Barr, Frederic G ^b   Ladanyi, Marc ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; EWING SARCOMA; FEMALE; GENE FUSION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; NEUROECTODERM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME;

EID: 0031924824     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.4.1248     Document Type: Article

References (39)

1. Delattre O, Zucman J, Plougastel B, et al: Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165, 1992
2. Delattre O, Zucman J, Melot T, et al: The Ewing family of tumors - A subgroup of small round-cell tumors defined by specific chimeric transcripts. New Engl J Med 331:294-299, 1994
3. Zucman J, Melot T, Desmaze C, et al: Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 12:4481-4487, 1993
4. Jeon I, Davis JN, Braun BS, et al: A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 10:1229-1234, 1995
5. Kaneko Y, Yoshida K, Handa M, et al: Fusion of an ETS-family gene. E1AF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosom Cancer 15:115-121, 1996
6. Urano F, Umezawa A, Hong W, et al: A novel chimera gene between EWS and E1AF, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 219:608-612, 1996
7. Peter M, Couturier J, Pacquement H, et al: A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 14:1159-1164, 1997
8. Barr FG, Chatten J, D'Cruz CM, et al: Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 273:553-557, 1995
9. de Alava E, Ladanyi M, Rosai J, et al: Detection of chimeric transcripts in desmoplastic small round-cell tumor and related developmental tumors by reverse-transcriptase polymerase chain reaction. A specific diagnostic assay. Am J Pathol 147:1584-1591, 1995
10. Granowetter L: Ewing's sarcoma and extracranial primitive neuroectodermal tumors. Curr Opin Oncol 7:355-360, 1995
11. Terrier P, Llombart-Bosch A, Contesso G: Small round blue cell tumors in bone: Prognostic factors correlated to Ewing's sarcoma and neuroectodermal tumors. Semin Diagn Pathol 13:250-257, 1996
12. Terrier P, Henry-Amar M, Triche TJ, et al: Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis? Eur J Cancer 31A:307-314, 1995
13. Siebenrock KA, Nascimento AG, Rock MG: Comparison of soft tissue Ewing's sarcoma and peripheral neuroectodermal tumor. Clin Orthop 329:288-299, 1996
14. Ohno T, Rao VN, Reddy ES: EWS/FLI-1 chimeric protein is a transcriptional activator. Cancer Res 53:5859-5863, 1993
15. May WA, Lessnick SL, Braun BS, et al: The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13:7393-7398, 1993
16. Bailly RA, Bosselut R, Zucman J, et al: DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14:3230-3241, 1994
17. Mao X, Miesfeldt S, Yang H, et al: The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem 269:18216-18222, 1994
18. May WA, Gishizky ML, Lessnick SL, et al: Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 90:5752-5756, 1993
19. Ouchida M, Ohno T, Fujimura Y, et al: Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 11:1049-1054, 1995
20. Kovar H, Aryee DN, Jug G, et al: EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ 7:429-437, 1996
21. Tanaka K, Iwakuma T, Harimaya K, et al: EWS-FLI1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 99:239-247, 1997
22. Sorensen PHB, Lessnick SL, Lopez-Terrada D, et al: A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nature Genet 6:146-151, 1994
23. Giovannini M, Biegel JA, Serra M, et al: EWS-ERG and EWS-FLI1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest 94:489-496, 1994
24. Dockhorn-Dworniczak B, Schfer L, Dantcheva R, et al: Diagnostic value of the molecular genetic detection of the 11;22 translocation in Ewing's tumours. Virchows Arch A Pathol Anat Histopathol 425:107-112, 1994
25. Melo JV: The diversity of bcr-abl fusion proteins and their relationship to leukemia phenotype. Blood 88:2375-2384, 1996
26. Zoubek A, Dockhorn-Dworniczak B, Delattre O, et al: Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 14:1245-1251, 1996
27. Picci P, Bohling T, Bacci G, et al: Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 15:1553-1559, 1997
28. Kushner BH, Meyers PA, Gerald WL, et al: Very high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 13:2796-2804, 1995
29. Terek RM, Brien EW, Marcove RC, et al: Treatment of femoral Ewing's sarcoma. Cancer 78:70-78, 1996
30. Sorensen PHB, Liu XF, Delattre O, et al: Reverse-transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood. Diag Mol Pathol 2:147-157, 1993
31. Ladanyi M: The emerging molecular genetics of sarcoma translocations. Diag Mol Pathol 4:162-173, 1995
32. Sorensen PH, Triche TJ: Gene fusions encoding chimeric transcription factors in solid tumours. Semin Cancer Biol 7:3-14, 1996
33. Plougastel B, Zucman J, Peter M, et al: Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 18:609-615, 1993
34. Rao VN, OhnoT, Prasad DD, et al: Analysis of the DNA-binding and transcriptional activation functions of human FLI-1 protein. Oncogene 8:2167-2173, 1993
35. Watson DK, Robinson L, Hodge DR, et al: FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1A function as ternary and quaternary complex factors on the EGR1 promoter serum response elements. Oncogene 14:213-221, 1997
36. Magnaghi-Jaulin L, Masutani H, Robin P, et al: SRE elements are binding sites for the fusion protein EWS-FLI-1. Nucleic Acids Res 24:1052-1058, 1996
37. Prasad DD, Rao VN, Reddy ES: Structure and expression of human FLI-1 gene. Cancer Res 52:5833-5837, 1992
38. Kelly KM, Womer RB, Sorensen PHB, et al: Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15:1831-1836, 1997
39. Kawai A, Woodruff J, Healey JH, et al: SYT-SSX fusion transcript structure as a determinant of morphology and prognosis in synovial sarcoma. New Engl J Med 338:153-160, 1998